"
Team:Potsdam Bioware
From 2012.igem.org
(→Team) |
(→Direct Antibody Identification, Maturation and Production in CHO-Cells) |
||
| Line 96: | Line 96: | ||
body { | body { | ||
| - | background-image: -ms-linear-gradient(left, #FFFFFF 0%, # | + | |
| - | background-image: -moz-linear-gradient(left, #FFFFFF 0%, # | + | background-image: -ms-linear-gradient(left, #FFFFFF 0%, #E3DFCF 100%); |
| - | background-image: -o-linear-gradient(left, #FFFFFF 0%, # | + | background-image: -moz-linear-gradient(left, #FFFFFF 0%, #E3DFCF 100%); |
| - | background-image: -webkit-gradient(linear, left top, right top, color-stop(0, #FFFFFF), color-stop(1, # | + | background-image: -o-linear-gradient(left, #FFFFFF 0%, #E3DFCF 100%); |
| - | background-image: -webkit-linear-gradient(left, #FFFFFF 0%, # | + | background-image: -webkit-gradient(linear, left top, right top, color-stop(0, #FFFFFF), color-stop(1, #E3DFCF)); |
| - | background-image: linear-gradient(to right, #FFFFFF 0%, # | + | background-image: -webkit-linear-gradient(left, #FFFFFF 0%, #E3DFCF 100%); |
| + | background-image: linear-gradient(to right, #FFFFFF 0%, #E3DFCF 100%); | ||
} | } | ||
Revision as of 11:11, 25 August 2012
| Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
|---|
Direct Antibody Identification, Maturation and Production in CHO-Cells
Project Description
Antibodies are versatile molecules for research and therapy and they are currently revolutionizing the market of biopharmaceuticals. To date, antibodies are generated in a laborious and time consuming manner. Either animal immunization followed by hybridoma technology or phage display is used to identify desired genes, which then need to be transferred to a production cell line such as CHO. We designed a streamlined workflow that incorporates all steps of antibody generation in CHO cells. Our plan is to stably transfect an antibody-fragment library in CHO cells. Antibody maturation is mimicked by further diversifying this library using the enzyme Activation-Induced cytidine Deaminase (AID), which is known to induce somatic hypermutation. Next, we plan to test and deploy a versatile and continuous viral selection system for clones producing the desired antibodies. Finally, we will try to employ a genetic switch to go from surface expression to soluble production of antibodies.
Team
